Janus Henderson Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141M | Buy |
|
|||||
|
2025
Q1 | $148M | Buy |
|
|||||
|
2024
Q4 | $70.7M | Buy |
|
|||||
|
2024
Q3 | $445K | Hold |
|
|||||
|
2024
Q2 | $261K | Sell |
|
|||||
|
2024
Q1 | $248K | Buy |
|
|||||
|
2023
Q4 | $289K | Sell |
|
|||||
|
2023
Q3 | $288K | Sell |
|
|||||
|
2023
Q2 | $107M | Buy |
|
|||||
|
2023
Q1 | $154M | Buy |
|
|||||
|
2022
Q4 | $107M | Sell |
|
|||||
|
2022
Q3 | $193M | Buy |
|
|||||
|
2022
Q2 | $97.9M | Sell |
|
|||||
|
2022
Q1 | $107M | Buy |
|
|||||
|
2021
Q4 | $125M | Sell |
|
|||||
|
2021
Q3 | $97.6M | Buy |
|
|||||
|
2021
Q2 | $57M | Sell |
|
|||||
|
2021
Q1 | $104M | Buy |
|
|||||
|
2020
Q4 | $111M | Buy |
|
|||||
|
2020
Q3 | $67.5M | Buy |
|
|||||
|
2020
Q2 | $59.4M | Buy |
|
|||||
|
2020
Q1 | $2.32M | Buy |
|